Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Death of Arcoxia: Drug Regulation in a "Whistleblower" Climate

May 01 2007

• By Kate Rawson

Related Content

Januvia: Defining Primary-Care Success and Risk

Mar 01 2007

Pfizer's Exubera: Breathing New Life Into Inhaled Insulin

Oct 01 2005

The New Economics of DTC: Responsibility Sells

Apr 01 2006

Dog Days for FDA: Agency Weathers a Stressful Spring

May 01 2007

Sanofi's Rimonabant: The Next Drug Safety Victim?

May 01 2007

The Next Cox-2 Battle: Merck, Novartis Drugs Face Vocal Resistance

Jan 01 2007

FDA's Drug Safety Changes: Safe Legislation; Unsafe Climate

Jan 01 2007

The Politics of Drug Safety: An FDA Whistleblower's Push for Reform

Mar 01 2007

Nervous Times for NDA Sponsors: The New Reality of FDA Drug Reviews

Apr 01 2007

The Power of the Purse: FDA Seeks More Money, Not More Authority

Feb 01 2007

Related Companies

Merck & Co., Inc.

Sanofi

Pfizer Inc.

Additional Topics

Business Strategies Leadership Regulation BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window